Top compounds associated with response to ERVV-2


Feature Type Standardized
Nominal ANOVA
mRNA nintedanib CTRPv2 pan-cancer AAC -0.011 0.8
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC -0.011 0.8
mRNA AT13387 CTRPv2 pan-cancer AAC -0.013 0.8
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.013 0.8
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.01 0.8
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.011 0.8
mRNA pandacostat CTRPv2 pan-cancer AAC 0.01 0.8
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.019 0.8
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0091 0.8
Download CSV